Related references
Note: Only part of the references are listed.Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases
Rainer J. Klement
RADIOTHERAPY AND ONCOLOGY (2017)
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
S. Tanadini-Lang et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control
R. J. Klement et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Semi-Competing Risks Data Analysis Accounting for Death as a Competing Risk When the Outcome of Interest Is Nonterminal
Sebastien Haneuse et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases
Rainer J. Klement et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy
Kamran A. Ahmed et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group stereotactic radiotherapy
Juliane Rieber et al.
LUNG CANCER (2016)
Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases
Nicolaus Andratschke et al.
RADIATION ONCOLOGY (2016)
Semi-Competing Risks Data Analysis Accounting for Death as a Competing Risk When the Outcome of Interest Is Nonterminal
Sebastien Haneuse et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
Kamran A. Ahmed et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
mice: Multivariate Imputation by Chained Equations inR
Stef van Buuren et al.
Journal of Statistical Software (2015)
frailtypack: AnRPackage for the Analysis of Correlated Survival Data with Frailty Models Using Penalized Likelihood Estimation or Parametrical Estimation
Virginie Rondeau et al.
Journal of Statistical Software (2015)
Predictive Factors for Local Control in Primary and Metastatic Lung Tumours after Four to Five Fraction Stereotactic Ablative Body Radiotherapy: A Single Institution's Comprehensive Experience
I. Thibault et al.
CLINICAL ONCOLOGY (2014)
Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival
Jon-Helge Angelsen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
Andreas Andreou et al.
ANNALS OF SURGERY (2012)
Stereotactic body radiotherapy for multisite extracranial oligometastases Final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease
Joseph K. Salama et al.
CANCER (2012)
Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study
Michael T. Milano et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
A 10-Year Single-Center Experience on 708 Lung Metastasectomies The Evidence of the International Registry of Lung Metastases
Monica Casiraghi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer
Atsuya Takeda et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Radiosurgery of Liver Tumors: Value of Robotic Radiosurgical Device to Treat Liver Tumors
Sebastian Stintzing et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Statistical Analysis of Illness-Death Processes and Semicompeting Risks Data
Jinfeng Xu et al.
BIOMETRICS (2010)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Kyle E. Rusthoven et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A rationale for the targeted treatment of oligometastases with radiotherapy
Dhara M. MacDermed et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Scaling regression inputs by dividing by two standard deviations
Andrew Gelman
STATISTICS IN MEDICINE (2008)
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases
Alan W. Katz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Stereotactic body radiation therapy (SBRT) for lung metastases
Paul Okunieff et al.
ACTA ONCOLOGICA (2006)
Stereotactic radiotherapy of primary liver cancer and hepatic metastases
Joern Wulf et al.
ACTA ONCOLOGICA (2006)
Share Paper
